In prostate cancer cells, similar interactions between AR and STAT5a/b signaling were shown (59) and in hepatocellular cancer, CBG expression is regulated via the pioneer factors FOXA1 and the estrogen receptor, potentially underlying sex differences in CBG (60). Here, ESR1 is linked to prostate carcinoma.